Navigation Links
Smell may outlast other senses

About 1000 Australian males and females of all ages were tested for their ability to detect or identify a range of different odours at different concentrations, and then given an overall score for their sense of smell, or olfactory function.

The results showed that olfactory function deteriorates relatively slowly with age in those who do not smoke, take medications or have a history of nasal problems such as sinusitis.

However the ability to smell drops off much quicker in older people who were taking medications ?also an indicator of underlying health problems.

Researcher Dr Amy Johnston, from Griffith University’s School of Nursing and Midwifery and the Eskitis Institute of Cell and Molecular Biology, said the study suggested that aging alone had a small detrimental effect on smell.

“However our sense of smell is vulnerable to both the direct effects of some medications and changes associated with a number of neurodegenerative illnesses. Exposure to these factors typically increases with age.?

Anticholesterol and blood pressure lowering medications were amongst the common drugs known to interfere with smell. Conditions such as Parkinson’s disease and Alzheimer’s disease were also associated with impairment in the sense of smell, she said.

Dr Johnston said the ability to smell was an important factor in the enjoyment of food flavours.

“People who lose their sense of smell, particularly the elderly, are at risk of poor appetite and subsequent poor nutrition. Smell is also an important warning sense ?telling people when food is not fit for consumption.?

Healthy women were shown to have a more sensitive sense of smell than healthy men but the gender effect was not apparent in smokers, people on medications or with a history of nasal problems.


'"/>

Source:Research Australia


Page: 1

Related biology news :

1. Smell of success for nanobiosensors
2. Get a whiff of this: Smell test could sniff out serious health problems
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Another Look Finds Promising Proteomics Test is Not Biologically Plausible
5. Elephants imitate truck noises, other animals
6. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
7. NJIT Presidential Award winner takes stem cell research another step
8. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
9. NASA links nanobacteria to kidney stones and other diseases
10. Anti cancer virotherapy well tolerated in first human administration, research finds
11. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smell may outlast other senses

(Date:11/30/2009)...ntific organisation is needed to monitor the commi...t Copenhagen to cut their deforestation rates, acc... Existing government agencies and research groups ...atellite images of the Earth,s surface collected e... paper published by Dr Alan Grainger in the Proce...
(Date:11/30/2009)... Clemson University researchers Ron Falta and Larr...Protection Agency grant to study the safe storage ... deep below the earth,s surface. , With carbon d...d to be the leading cause of global warming, geolo...g alternatives for reducing emissions using curren...
(Date:11/30/2009)...ase is available in German . , The DFG has ... Research Centres as of 1 January 2010. This decis...ttee in Bonn. The new centres will initially be fu...n addition, 20 percent overhead funding for indire...he centres, research topics range from modern pros...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 2Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 1Par Pharmaceutical Receives Final Approval to Market Generic Ultram 28R 29 ER 6276 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
...overed a new technique for turning embryonic stem ...what could prove a significant breakthrough in the... University of Manchester team, working with colle... genetically manipulate the stem cells so that the...iption factor. , Stem cells have the ability to b...
...f Pittsburgh of UPMC a national leader in the use...or children in heart failure is part of a collabo...on grant from the National Institutes of Health (N...cifically for small children. , VADs are mechanic...e heart and offer lifesaving support, most often a...
...end bird feeders in their backyards each year, oft... survey of research on the topic finds that feedin...birds. , Published as a Frontiers in Ecology an...ology.org ), the meta-analysis led by Gillian Robb...rhop (University of Exeter, UK) reviewed results f...
Other Biology News:Stem cell breakthrough offers diabetes hope 2Children's Hospital leads projects to develop nation's first heart assist devices for young children 2Children's Hospital leads projects to develop nation's first heart assist devices for young children 3Food for thought 2
(Date:11/30/2009)...ATO, Calif., Nov. 30 Bio...ed today that the Food and Drug Administration (FD...minopyridine (3,4-DAP), amifampridine phosphate, f...henic Syndrome (LEMS). 3,4-DAP has previously rec...n October 2009, the Committee for Medicinal Produc...
(Date:11/30/2009)... , LONDON, November 30 Apa...was named Europe,s fastest growing,Biotech/Pharmac...e Deloitte,2009 Technology Fast 500 for EMEA (Euro...l ranking is based on a companies, five-year reven...f 8,318% over this period. This,achievement places...
(Date:11/27/2009)... PARIS, November 27 Sta...rket Oralair(R) in both adults and children,throug...st country where,Oralair(R) has been marketed, was... is now registered in Austria, Belgium, Bulgaria, ...ny, Greece, Hungary, Ireland, Italy,Latvia, Lithu...
(Date:11/25/2009)... Ambassador to Speak at Economic Club o...a (Vocus) November 25, 2009 -- Ambassador to Speak...Appia, French Ambassador for International Investm...Agency ,To view a biography of David Appia go to ...ppia is available to meet with press to discuss re...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3French Ambassador for International Investment to Visit Toronto December 11 2
... Increasing Case Volumes Drive 78 Percent Revenue ...o the Prior Year Period , , ALISO VIEJO, Calif., ...emier anatomic pathology and molecular testing ser...the pharmaceutical industry, today reported prelim... year ended December 31, 2008. Financial results ...
...arch 11 XTL Biopharmaceuticals Ltd. (Nasdaq: XT...nary General Meetings ("EGMs") were postponed for ...ation due to the absence of a quorum. The postpone... Kiryat Weizmann Science Park, Rehovot, Israel 761... 18, 2009. , , Any proxy votes received at any ti...
...H, Switzerland, March 11 Simbionix,the world,s le... VirtaMed, a,Swiss medical engineering company, an...mbionix will exclusively distribute, market, and p...ed virtual reality hysteroscopy simulator. , S...ors for minimal,invasive surgery. "This new agreem...
Other Biology Technology:Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 2Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 3Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 4Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 5Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 6Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 7Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 8Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 9Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 10Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 11Simbionix Increases Product Offerings for OB/GYN Physicians 2
Rabbit Anti-MD-2 (IN) Polyclonal Antibody, Unconjugated from AnaSpec
Anti-MPM-2, phospho-Ser / Thr-Pro (Mitotic protein monoclonal #2) Antibody, Agarose Conjugated from Upstate
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Calcium Channel alpha 2 delta-2 Monoclonal Antibody, Unconjugated, Clone 42 from BD Biosciences Pharmingen
Biology Products: